"Opening an office in the United States is a natural geographic addition for our overall global growth strategy. As we continue to add clients, backlog, feature sets and staff in the U.S. it was an easy choice for us to open an office in San Diego.", said Pavel Marek M.D., CEO, Neox.
Heading up the U.S. operations is Matt Delaney, Managing Director, Neox U.S. Matt is an industry executive with more than 25 years of experience. Matt was previously Vice President of worldwide sales and marketing for a mid-size global CRO. "We are delighted to have Matt join the Neox team. Matt's experience in building and managing regions and teams will be a key ingredient for Neox's overall success", said Pavel Marek.
"I am excited about joining the Neox team, during this important time in the company's history", said Matt Delaney. "Targeted geographic expansion coupled with our intent to develop strategic partnerships will further accelerate and enhance our overall growth strategy". Matt went on to say "conducting trials in Central and Eastern Europe has distinct advantages for locating patients, accelerating regulatory approval, finding sites and conducting clinical trials quickly and efficiently."
Neox also strengthens its management team in Europe. Jennifer Haggard, MS, has been hired to act as the Managing Director of Neox Europe. She is strategically located in a newly opened Neox office in Aachen, Germany. Jen has a long-lasting experience from both CRO and Pharma industries. "I believe that Jen is the key person for the overall management of European operations", said Pavel Marek. "I am delighted to be a part of the Neox team. Our experience conducting trials in CEE countries is significant and further expansion throughout Europe is paramount for Neox," Jen stated.
For further information about conducting clinical trials with Neox please contact us via email at email@example.com or North America:
Matt Delaney, Managing Director Neox USA, at firstname.lastname@example.org, tel: +1 512 922.2839
Outside of North America: Jennifer Haggard, Managing Director Neox Europe, email@example.com
Neox delivers clinical trials to pharmaceutical, biotechnology, medical device and other CRO's throughout Europe, with a strong presence in Central and Eastern Europe (CEE). Having more than 350 clinical research professionals in all CEE countries and Western Europe, and another 50 employees in partnering CRO's, makes Neox one of the largest European CRO's.
Neox is a full service CRO, offering clinical services for Phase I-IV studies in addition to complimentary services such as biostatistics, clinical monitoring, data management, eCRF design, eDiaries, drug safety, medical monitoring, medical writing, pharmacovigilance and safety, project management, quality assurance, regulatory and ethics committee submissions, site contracting, training and education.
The Neox team of dedicated professionals are located strategically in the field in some of the most densely populated regions of Western, Central & Eastern Europe. Years of clinical experience, understanding local regulatory requirements, established relationships with investigators ensures clients trials gets underway and finishes on time and within budget. Neox office locations are in - Austria, Bulgaria, Croatia, Czech Republic, Finland, France, Germany, Hungary, Poland, Serbia, Slovakia, Spain and in the United States of America. As well, Neox has established partners in Italy and Baltic countries.